Denali Therapeutics Inc.
Compounds, compositions and methods
Last updated:
Abstract:
The present disclosure relates generally to compounds and compositions, and their use as kinase inhibitors.
Status:
Grant
Type:
Utility
Filling date:
13 Sep 2018
Issue date:
31 Mar 2020